Safety and Efficacy Study for MG-7-DC Vaccine in Gastric Cancer Treatment
Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
The primary purpose of the study is to determine the safety and efficacy of autologous DC
vaccine in patients with later stage of gastric cancer. The DC vaccine is gene modified with
gastric cancer specific antigen MG-7.